LINC00922 and breast carcinoma: LINC00922 is obviously overexpressed in breast cancer tissues and cell lines, and therefore increasing the expression of the miR-424-5p/BDNF axis can reduce the expression of LINC00922 and weaken its effects on promoting the proliferation, apoptosis, migration and invasion of breast cancer cells [69].